GNH USA

Europe — EMA

Nplate (Romiplostim)

Romiplostim, the active ingredient in Nplate, is a thrombopoietin receptor agonist presented as a unknown/unknown for subcutaneous use.

Request sourcing

1
Pack/s

What is Romiplostim?

Romiplostim, the active ingredient in Nplate, is a thrombopoietin receptor agonist presented as a unknown/unknown for subcutaneous use. It stimulates platelet production and is used to manage chronic immune thrombocytopenia in adults and children.

GNH USA supplies Nplate as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

What is Romiplostim used for?

Nplate is a thrombopoietin receptor agonist that acts on the platelet production pathway. - Chronic immune thrombocytopenia (ITP): Increases the platelet count to achieve a safe level for patients with persistent low platelets. - Secondary ITP associated with HIV or Hepatitis C infection : Hel   -   -  . - . - .

What precautions apply to Romiplostim?

[]

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Romiplostim
Route
Subcutaneous Use
Manufacturer
Amgen Europe B.V.
Origin
EU

Related products